Experts: FDA approves much-debated Alzheimer's drug panned by experts

Published: 10 June 2021

U.S. government health officials approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been...

McGill researchers identify correlation between mild behavioural impairment and Alzheimer’s

Published: 8 April 2020

New research from McGill University has found that the presence and severity of mild behavioural impairment (MBI) in cognitively healthy individuals is strongly associated with the presence of...

McGill study identifies new role of major genetic risk factor in Alzheimer’s disease

Published: 20 December 2019

For years, physicians have been aware that patients carrying the apolipoprotein ꜫ4 (APOE ꜫ4) gene are at a greater risk of developing Alzheimer’s disease. New research from McGill University has...

AI Could Predict Cognitive Decline Leading to Alzheimer’s Disease in the Next 5 Years

Published: 4 October 2018

A team of scientists has successfully trained a new artificial intelligence (AI) algorithm to make accurate predictions regarding cognitive decline leading to Alzheimer’s disease.

New mechanism detected in Alzheimer’s disease

Published: 13 October 2017

By Chris Chipello McGill University researchers have discovered a cellular mechanism that may contribute to the breakdown of communication between neurons in Alzheimer’s disease.

Could olfactory loss point to Alzheimer’s disease?

Published: 15 August 2017

By the time you start losing your memory, it's almost too late. That's because the damage to your brain associated with Alzheimer’s disease (AD) may already have been going on for as long as twenty...

Pages

Back to top